Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
| 2.75 Delayed Data As of Aug 22 |  +0.08 / +3.00%Today’s Change | 1.22 Today|||52-Week Range 5.55 | +93.66% Year-to-Date |
The 1 analysts offering 12-month price forecasts for Cleveland Biolabs Inc have a median target of 40.00, with a high estimate of 40.00 and a low estimate of 40.00. The median estimate represents a +1,354.55% increase from the last price of 2.75.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.
